ストックスクリーナーアプリを入手
11.04
0.27%
-0.025
Solid Biosciences Inc (SLDB) 最新ニュース
Solid Biosciences (SLDB) Gains 2.12% as Biotech Momentum BuildsBreakout Stock Alerts - dars.gov.et
Solid Biosciences (SLDB) Surges 6.27% as Biotech Sentiment ImprovesTrend Reversal Picks - dars.gov.et
Solid Biosciences stock hits 52-week high at $10.44 By Investing.com - Investing.com Canada
Solid Biosciences: The Bull Case Is No Longer Just Duchenne - Seeking Alpha
Does Solid Biosciences' (SLDB) Russell Index Debut Hint at a Turning Point in Its Growth Story? - simplywall.st
Does Solid Biosciences' (SLDB) Russell Growth Index Debut Reveal a Shift in Its Investor Base? - Yahoo Finance
RA CAPITAL MANAGEMENT, L.P. Increases Stake in Solid Biosciences Inc. - GuruFocus
Solid Biosciences Inc.(NasdaqGS:SLDB) added to Russell Small Cap Comp Growth Benchmark - marketscreener.com
Solid Biosciences Inc.(NasdaqGS: SLDB) added to Russell 2500 Growth Benchmark - marketscreener.com
Solid Biosciences Inc.(NasdaqGS: SLDB) added to Russell 2000 Growth Benchmark - marketscreener.com
Solid Biosciences Inc.(NasdaqGS: SLDB) added to Russell 3000E Growth Benchmark - marketscreener.com
Solid Biosciences Inc.(NasdaqGS: SLDB) added to Russell 3000 Growth Benchmark - marketscreener.com
Price to sales forward of Solid Biosciences Inc. – NASDAQ:SLDB - TradingView
Enterprise value to EBITDA forward of Solid Biosciences Inc. – NASDAQ:SLDB - TradingView
Price to book forward of Solid Biosciences Inc. – NASDAQ:SLDB - TradingView
Price to earnings forward of Solid Biosciences Inc. – NASDAQ:SLDB - TradingView
SLDB Forecast — Price Target — Prediction for 2027 - TradingView
Solid Biosciences Inc. Actuals & Estimates (NASDAQ:SLDB) - TradingView
Solid Biosciences Inc (SLDB) Valuation: PE, PB & Fair Value Analysis - TradingKey
Form 13D/A SOLID BIOSCIENCES INC. For: 24 June By Investing.com - Investing.com Australia
RA Capital discloses large SLDB stake with 8.18M pre-funded warrants - Stock Titan
RA Capital (NASDAQ: SLDB) boosts Solid Biosciences holding to 11.9% ownership - Stock Titan
Solid Biosciences Inc (SLDB) Institutional Confidence - TradingKey
Solid Biosciences Inc.(NasdaqGS: SLDB) added to S&P Biotechnology Select Industry Index - marketscreener.com
Solid Biosciences Jumps As H.C. Wainwright Lifts Price Target - timothysykes.com
SLDB Jumps As Analyst Hikes Price Target To $25 - timothysykes.com
SLDB Jumps As H.C. Wainwright Hikes Price Target To $25 - timothysykes.com
Selling US$823k Of Solid Biosciences Stock Rewarded Insiders - Moomoo
Is Solid Biosciences (NASDAQ:SLDB) In A Good Position To Invest In Growth? - Sahm
Solid Biosciences Inc (SLDB) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Solid Biosciences Inc (SLDB) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Solid Biosciences Inc (SLDB) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Solid Biosciences Inc (SLDB) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Solid Biosciences Inc. targets platform partnerships at BIO2026 in San Diego - Traders Union
Solid Biosciences Inc (SLDB) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Solid Biosciences Inc (SLDB) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Solid Biosciences Inc (SLDB) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Solid Biosciences grants 77,500 options to director | SLDB Insider Trading - Stock Titan
Director at Solid Biosciences (NASDAQ: SLDB) granted 77,500 options - Stock Titan
Solid Biosciences (SLDB) director awarded 77,500 stock options at $6.61 strike - Stock Titan
Solid Biosciences (SLDB) director awarded 77,500 options via Perceptive Advisors - Stock Titan
Director at Solid Biosciences (SLDB) granted 77,500 stock options at $6.61 - Stock Titan
Solid Biosciences (SLDB) director receives 77,500 stock options at $6.61 exercise price - Stock Titan
Director at Solid Biosciences (NASDAQ: SLDB) receives 77,500 stock options grant - Stock Titan
Solid Biosciences (SLDB) grants director 77,500 stock options at $6.61 - Stock Titan
Solid Biosciences director granted 77,500 options | SLDB Insider Trading - Stock Titan
Solid Biosciences Shareholders Approve Directors and Share Increase - TipRanks
Solid Biosciences (NASDAQ: SLDB) shareholders approve doubling authorized stock - Stock Titan
Solid Biosciences Inc. targets industry collaboration ahead of BIO2026 to accelerate genetic medicine - Traders Union
Should I Buy SLDB (Solid Biosciences Inc.) | AI Analysis, Technical & News Insights - Kavout
SLDB: Gene therapy programs show robust efficacy, safety, and regulatory momentum for key indications - TradingView
Solid Biosciences Inc at Goldman Sachs Healthcare Conference Transcript - GuruFocus
Solid Biosciences (SLDB) Goldman Sachs 47th Annual Global Healthcare Conference 2026 summary - Quartr
Analysts Offer Insights on Healthcare Companies: Vera Therapeutics (VERA) and Solid Biosciences (SLDB) - The Globe and Mail
SLDB (NASDAQ: SLDB) supplement lists updated selling stockholders and holdings - Stock Titan
Solid Biosciences Rises as Investors Focus on Rare-Disease Pipeline - Bez Kabli
Citi Maintains Solid Biosciences(SLDB.US) With Buy Rating, Maintains Target Price $14 - Moomoo
H.C. Wainwright raises Solid Biosciences price target on FA trial progress - Investing.com UK
SLDB Maintained by HC Wainwright & Co. -- Price Target Raised to $25 - GuruFocus
SLDB: Duchenne and FA gene therapy programs show strong progress, with pivotal FDA meetings ahead - TradingView
H.C. Wainwright raises Solid Biosciences price target on FA trial progress By Investing.com - Investing.com South Africa
1.21%
3.14%
大文字化:
|
ボリューム (24 時間):